Involvement of leukotriene B4 in dermatophyte-related itch in mice

Tsugunobu Andoh1, Yusuke Takayama1, Yasushi Kuraishi1

  • 1Department of Applied Pharmacology, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Sugitani, Japan.

Abstract

Insights

Proteinase-activated receptor-2 (PAR2) activation leads to leukotriene B4 (LTB4) production, causing dermatophyte-induced scratching. Inhibiting PAR2 or LTB4 pathways effectively reduces this itch response in mice.

Area of Science:

  • Dermatology
  • Immunology
  • Pharmacology

Background:

  • Proteinase-activated receptor-2 (PAR2) plays a role in skin responses to dermatophytes, including scratching and leukotriene B4 (LTB4) release.
  • Keratinocytes are a key source of LTB4 in the skin.

Purpose of the Study:

  • To investigate the role of PAR2-mediated LTB4 production in dermatophyte-induced scratching.
  • To determine if blocking PAR2 or LTB4 pathways can alleviate scratching.

Main Methods:

  • Mice were injected intradermally with dermatophyte extract to induce scratching.
  • LTB4 levels were quantified using enzyme immunoassay.
  • Pharmacological inhibitors and antagonists (zileuton, ONO-4057, FSLLRY-NH2, anti-PAR2 antibody) were used to assess their effects on scratching and LTB4 production.

Main Results:

  • Dermatophyte extract induced significant scratching behavior in mice.
  • Scratching was significantly reduced by zileuton (5-lipoxygenase inhibitor), ONO-4057 (LTB4 antagonist), FSLLRY-NH2 (PAR2 antagonist), and anti-PAR2 antibody.
  • Dermatophyte extract injection increased cutaneous LTB4 levels, which were suppressed by zileuton and FSLLRY-NH2.

Conclusions:

  • LTB4 is implicated in the itch sensation associated with dermatophyte infections.
  • PAR2 stimulation in the skin appears to be a primary mechanism for LTB4 production.
  • Targeting the PAR2-LTB4 pathway offers a potential therapeutic strategy for dermatophyte-induced pruritus.